SCHEMBL29410342

SCHEMBL29410342

C=CC(=O)Nc1cccc(F)c1C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 2/20 0.55
ALDH1A1 P00352 3/20 0.49
GAA P10253 1/20 0.49
BTK Q06187 4/20 0.46
TEC P42680 1/20 0.46
TXK P42681 1/20 0.46
BMX P51813 1/20 0.46
JAK3 P52333 1/20 0.46
ITK Q08881 1/20 0.46
ERBB4 Q15303 1/20 0.46
TGM2 P21980 4/20 0.46
KDR P35968 1/20 0.43
EPHB4 P54760 1/20 0.43
TEK Q02763 1/20 0.43
EGFR P00533 1/20 0.43
MMP1 P03956 1/20 0.43
MMP2 P08253 1/20 0.43
MMP9 P14780 1/20 0.43
THRB P10828 1/20 0.43
GSTO1 P78417 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25294216 1.00 SMN1; SMN2 (0.55) SMN1; SMN2ALDH1A1GAABTKTEC
SCHEMBL31162452 0.83 NPC1 (0.51) ALDH1A1GAABTKTECTXK
SCHEMBL29505780 0.83 TGM2 (0.49) SMN1; SMN2ALDH1A1TGM2KDREPHB4
SCHEMBL17931668 0.83 NPC1 (0.51) ALDH1A1GAABTKTECTXK
SCHEMBL18765284 0.83 TGM2 (0.49) SMN1; SMN2ALDH1A1TGM2KDREPHB4
SCHEMBL2091233 0.82 SMN1; SMN2 (0.61) SMN1; SMN2ALDH1A1GAATHRBNPC1
SCHEMBL1379801 0.82 ALDH1A1 (0.64) SMN1; SMN2ALDH1A1TGM2KDREPHB4
SCHEMBL26406362 0.82 SMN1; SMN2 (0.54) SMN1; SMN2ALDH1A1GAABTKEGFR
SCHEMBL7191119 0.81 BTK (0.49) ALDH1A1GAABTKTECTXK
SCHEMBL21752371 0.81 SMN1; SMN2 (0.52) SMN1; SMN2ALDH1A1GAAEGFRMMP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4486721-A1 ACRYLAMIDE COMPOUNDS NRG Therapeutics LTD (GB) 2025-01-08 EP disclosed
CN-118804911-A Acrylamide compound NRG治疗有限公司 2024-10-18 CN disclosed
WO-2023166303-A1 ACRYLAMIDE COMPOUNDS NRG THERAPEUTICS LTD (GB) 2023-09-07 WO disclosed
EP-4208442-A1 NOVEL COMPOUNDS NRG Therapeutics LTD (GB) 2023-07-12 EP disclosed
EP-4208448-A1 NOVEL COMPOUNDS NRG Therapeutics LTD (GB) 2023-07-12 EP disclosed
CN-116096705-A Novel compounds NRG治疗有限公司 2023-05-09 CN disclosed
CN-116096712-A Novel compounds NRG治疗有限公司 2023-05-09 CN disclosed
WO-2022049376-A1 NOVEL COMPOUNDS NRG THERAPEUTICS LTD (GB) 2022-03-10 WO disclosed
WO-2022049377-A1 NOVEL COMPOUNDS NRG THERAPEUTICS LTD (GB) 2022-03-10 WO disclosed